| Ytd | -29.82% | |
| 1y | -14.68% |
| Open | 120.65 | Prev Close | 118.95 | Low | 119.80 | High | 125.68 | Mkt Cap | 4.09B |
| Vol | 624.46K | Avg Vol | 532.89K | EPS | -0.85 | P/E | N/A | Forward P/E | 113.15 |
| Beta | 1.28 | Short Ratio | 5.57 | Inst. Own | 111.14% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-30 | 50-d Avg | 115.32 | 200-d Avg | 147.84 | 1yr Est | 178.93 |
NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is i
BTIG analyst Marie Thibault reiterates iRhythm Holdings (NASDAQ:IRTC) with a Buy and maintains $1
Health care sector's oversold stocks present buying opportunity; RSI below 30 signals oversold,
iRhythm says hackers stole patient and proprietary data from third-party apps but sees no material i
Material Cybersecurity Incidents. On June 8, 2026, iRhythm Holdings, Inc. (the "Company") id
BTIG analyst Marie Thibault reiterates iRhythm Holdings (NASDAQ:IRTC) with a Buy and maintains $1
On June 3, 2026, iRhythm Technologies, Inc. ("iRhythm Tech"), a wholly owned subsidiary of i
Canaccord Genuity analyst William Plovanic maintains iRhythm Holdings (NASDAQ:IRTC) with a Buy an
B of A Securities analyst Stephanie Piazzola maintains iRhythm Holdings (NASDAQ:IRTC) with a Buy
Citigroup analyst Joanne Wuensch maintains iRhythm Holdings (NASDAQ:IRTC) with a Buy and raises t
Canaccord Genuity analyst William Plovanic maintains iRhythm Holdings (NASDAQ:IRTC) with a Buy an
JP Morgan analyst Allen Gong maintains iRhythm Holdings (NASDAQ:IRTC) with a Overweight and lower
Wells Fargo analyst Nathan Treybeck maintains iRhythm Holdings (NASDAQ:IRTC) with a Overweight an
Evercore ISI Group analyst Vijay Kumar maintains iRhythm Holdings (NASDAQ:IRTC) with a Outperform
Needham analyst David Saxon maintains iRhythm Holdings (NASDAQ:IRTC) with a Buy and raises the pr
iRhythm Holdings (NASDAQ:IRTC) raises FY2026 sales outlook from $870.000 million-$880.000 million to
iRhythm Technologies (NASDAQ:IRTC) reported quarterly losses of $(0.35) per share which beat the ana
Truist Securities analyst Richard Newitter maintains iRhythm Holdings (NASDAQ:IRTC) with a Buy an
Goldman Sachs analyst David Roman maintains iRhythm Holdings (NASDAQ:IRTC) with a Neutral and low
Evercore ISI Group analyst Vijay Kumar maintains iRhythm Holdings (NASDAQ:IRTC) with a Outperform
Citigroup analyst Joanne Wuensch maintains iRhythm Holdings (NASDAQ:IRTC) with a Buy and lowers t
Truist Securities analyst Richard Newitter reiterates iRhythm Holdings (NASDAQ:IRTC) with a Buy a
Canaccord Genuity analyst William Plovanic maintains iRhythm Holdings (NASDAQ:IRTC) with a Buy an
JP Morgan analyst Allen Gong maintains iRhythm Holdings (NASDAQ:IRTC) with a Overweight and lower
Wells Fargo analyst Nathan Treybeck maintains iRhythm Holdings (NASDAQ:IRTC) with a Overweight an
Baird analyst Mike Polark maintains iRhythm Holdings (NASDAQ:IRTC) with a Outperform and lowers t
iRhythm Holdings (NASDAQ:IRTC) affirms FY2026 sales outlook from $870.000 million-$880.000 million t
iRhythm Technologies (NASDAQ:IRTC) reported quarterly earnings of $0.29 per share which beat the ana
iRhythm shares slid after a Zio MCT delay, but William Blair says the selloff is overdone and keeps
Wells Fargo analyst Nathan Treybeck maintains iRhythm Technologies (NASDAQ:IRTC) with a Overweigh
Needham analyst David Saxon reiterates iRhythm Technologies (NASDAQ:IRTC) with a Buy and maintain
iRhythm Technologies (NASDAQ:IRTC) sees FY2026 sales of $870.000 million-$880.000 million vs $862.68
iRhythm Technologies (NASDAQ:IRTC) raises FY2025 sales outlook from $735.000 million-$740.000 millio
Recent Operational Highlights and Financial OutlookAnticipate full year 2025 revenue to exceed high
Evercore ISI Group analyst Vijay Kumar upgrades iRhythm Technologies (NASDAQ:IRTC) from In-Line t
Truist Securities analyst Richard Newitter maintains iRhythm Technologies (NASDAQ:IRTC) with a Bu
Morgan Stanley analyst Cecilia Furlong maintains iRhythm Technologies (NASDAQ:IRTC) with a Overwe
iRhythm Technologies presented new data during the joint Asia Pacific Heart Rhythm Society (APHRS) a
Real-world data across more than 1 million patients published in Heart Rhythm show that 24–48-hour m
Canaccord Genuity analyst William Plovanic maintains iRhythm Technologies (NASDAQ:IRTC) with a Bu
Citigroup analyst Joanne Wuensch maintains iRhythm Technologies (NASDAQ:IRTC) with a Buy and rais
JP Morgan analyst Allen Gong maintains iRhythm Technologies (NASDAQ:IRTC) with a Overweight and r
iRhythm Technologies beat Q3 estimates with record revenue, raised its 2025 sales outlook, and gaine